Skip to main content
Premium Trial:

Request an Annual Quote

German Firm MTM Laboratories Raises $9.8M in Series C Round

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German diagnostics firm MTM Laboratories announced today an additional tranche of €7 million ($9.8 million) to its Series C financing round.

The funds are an expansion of MTM's Series C from October 2009 and brings the total amount raised in the round to €46 million, the Heidelberg firm said.

Existing investors HBM BioVentures, Wellington Partners, and Gilde Healthcare Partners led the round. A consortium including National Technology Enterprises, Heidelberg Innovation, and private investors also participated.

In a statement, MTM CEO Bob Silverman said the funds will support clinical trials and commercialization efforts, and added that a large portion will go toward funding the US regulatory clinical trials for the company's CINtec Plus Cytology platform for a PMA submission.

The system is a screening and diagnostic tool that combines high sensitivity with high specificity for the detection of high-grade cervical disease in a single test. The CINtec Plus kit detects and stains for two biomarkers, cell cycle regulatory protein p16INK4a, and Ki-67.

The system was launched in Europe in March. It is CE marked and is undergoing clinical trials.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.